tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Francois Brisebois, 102 are a BUY (93.58%), 7 are a HOLD (6.42%).
Analyst Francois Brisebois, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 22.73% that have a potential upside of 34.07% achieved within 144 days.
Francois Brisebois’s has documented 204 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TARS, Tarsus Pharmaceuticals at 22-Jan-2025.
Analyst best performing recommendations are on DMTK (DERMTECH).
The best stock recommendation documented was for DMTK (DERMTECH) at 1/22/2021. The price target of $53 was fulfilled within 14 days with a profit of $10.08 (23.49%) receiving and performance score of 16.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$21
$13.15 (167.52%)
$25
20 days ago
(10-Jan-2025)
4/12 (33.33%)
$13.29 (172.37%)
380
Buy
$13
$5.15 (65.61%)
$18
20 days ago
(10-Jan-2025)
4/5 (80%)
$5.29 (68.61%)
1060
Buy
$19
$11.15 (142.04%)
$22
21 days ago
(09-Jan-2025)
20/31 (64.52%)
$8.31 (77.74%)
319
Buy
$30
$22.15 (282.17%)
$27
2 months 30 days ago
(31-Oct-2024)
6/14 (42.86%)
$14.53 (93.92%)
440
Buy
$18
$4.69 (35.24%)
$16
1 years 7 months ago
(30-Jun-2023)
2/4 (50%)
$1.52 (9.22%)
169
Which stock is Francois Brisebois is most bullish on?
Which stock is Francois Brisebois is most reserved on?
What Year was the first public recommendation made by Francois Brisebois?
